Narita, Takeo, Autocrine Growth Factor and Spontaneous Transformation of Rat Liver Epithelial Cells, In Vitro Cell. Dev. Biol. (1990), 26 (4), 330-4.* |
Effect of Testosterone on the Growth Properties and on Epidermal Growth Factor Receptor Expression in the Teratoma-derived Tumorigenic Cell Line 1246 -3A, Serrero, G. et al., Cancer Research 52, 1992, pp. 4242-4247. |
Molecular Biology of the Cell, Alberts, B., et al., Garland Publishing, Inc., 1983. |
Growth Factors in Development, Transformation, and Tumorigenesis, Cross, M. et al., Cell, vol. 64, 1991, pp. 271-280. |
Autocrine Secretion and Malignant Transformation of Cells, Sporn, M.B. et al., The New England Journal of Medicine, vol. 303, 1980, pp. 878-880. |
Purification of an Autocrine Growth Factor Homologous with Mouse Epithelin Precursor from a Highly Tumorigenic Cell Line, Zhou, J. et al., The Journal of Biological Chemistry, vol. 268, No. 15, 1993, pp. 10863-10869. |
The Epithelin Precursor Encodes Two Proteins with Opposing Activities on Epithelial Cell Growth, Plowman, G. et al., The Journal of Biological Chemistry, vol. 267, No. 18, 1992, pp. 13073-13078. |
Granulins, a Novel Class of Peptide from Leukocytes, Bateman, A. et al., Biochemical and Biophysical Research Communications, vol. 173, No. 3, 1990, pp. 1161-1168. |
A Synthetic Fragment of Rat Transforming Growth Factor with Receptor Binding and Antigenic Properties, Nestor, J. et al., Biochemical and Biophysical Research Communications, vol. 129, No. 1, 1985, pp. 226-232. |
In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone, Adelman, J. et al., DNA, vol. 2, No. 3, 1983, pps. 183-193. |
An In Vitro Model to Study Adipose Differentiation in Serum-Free Medium, Serrero, G. et al., Analytical Biochemistry 120, 1982, pp. 351-359. |
Study of a Teratoma-Derived Adipogenic Cell Line 1246 and Isolation of an Insulin-Independent Variant in Serum-Free Medium, Serrero-Dave, G., Cancer Center, University of California, pp. 366-376. |
Tumorigenicity Associated with Loss of Differentiation and of Response to Insulin in the Adipogenic Cell Line 1246, Serrero, G., In Vitro Cellular & Developmental Biology, vol. 21, No. 9, 1985, pp. 537-540. |
Decreased Transforming Growth Factor-β Response and Binding in Insulin-independent Teratoma-Derived Cell Lines with Increased Tumorigenic Properties, Serrero, G. et al., Journal of Cellular Physiology, 149, 1991, pp 503-511. |
Growth Inhibition of Human Breast Cancer Cells in Vitro with an Antibody against the Type I Somatomedin Receptor, Arteaga, C. et al., Cancer Research 49, 1989, pp. 6237-6241. |
The Biological Effects of a High Molecular Weight Form of IGF II in a Pluripotential Human Teratocarcinoma Cell Line, Schofield, P. et al., Anticancer Research 14, 1994, pp. 533-538. |
Gene therapy of murine teratocarcinoma: Separate functions for insulin-like growth factors I and II in immunogenicity and differentiation, Trojan, J. et al., Proc. Natl. Acad. Sci. USA, vol. 91, 1994, pp. 6088-6092. |
Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA, Trojan, J. et al., Science, vol. 259, 1993, pp. 94-96. |
Continuous cultures of fused cells secreting antibody of predefined specificity, Kohler, G. et al., Nature, vol. 256, 1975, pp. 495-497. |
Production of Monoclonal Antibodies: Strategy and Tactics, de St. Groth, S.F. et al., Journal of Immunology Methods, 35, 1980, pp. 1-21. |
Hybridoma Techniques, Schreier, M. et al., Cold Spring Harbor Laboratory, 1980. |
Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli, Cabilly, S. et al., Proc. Natl. Acad. Sci. USA, vol. 81, 1984, pp. 3273-3277. |
Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains, Morrison, S. et al., Proc. Natl. Acad. Sci. USA, vol. 81, 1984, pp. 6851-6855. |
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells, Liu, A. et al., Proc. Natl. Acad. Sci. USA, vol. 84, 1987, pp. 3439-3443. |
Escherichia coli Secretion of an Active Chimeric Antibody Fragment, Better, M. et al., Science, vol. 240, 1988, pp. 1041-1043. |
Reshaping human antibodies for therapy, Riechmann, L. et al., Nature, vol. 332, 1988, pp. 323-327. |
Antibody Humanization Using Monovalent Phage Display, Baca, M. et al., J. Biol. Chem., vol. 272, No. 16, 1997, pp. 10678-10684. |
A Combination Library Strategy for the Rapid Humanization of Anticarcinoma BR96 Fab, Rosok, M.J. et al., J. Biol. Chem., vol. 271, No. 37, 1996, pp. 22611-22618. |
Improved Radioimaging and Tumor Localization with Monoclonal F(ab'), Wahl, R.L. et al., The Journal of Nuclear Medicine, vol. 24, No. 4, 1983, pp. 316-325. |
Clinical Use of a Monoclonal Antibody to Bombesin-lik Peptide in Patients with Lung Cancer, Mulshine, J.L., Annals New York Academy of Sciences, pp. 360-372. |
Antisense RNA inhibits splicing of pre-mRNA in vitro, Munroe, S.H., The EMBO Journal, vol. 7, No. 8, 1988, pp. 2523-2532. |
Specific Synthesis of DNA in Vitro via a Polymerase-Catalyzed Chain Reaction, Mulis, K.B. et al., Methods in Enzymology, vol. 155, 1987, pp. 335-350. |
Antisense approaches to cancer gene therapy, Mercola, D. et al., Cancer Gene Therapy, vol. 2, No. 1, 1995, pp. 47-59. |
Gene inhibition using antisense oligodeoxynucleotides, Wagner, R. W., Nature, vol. 372, 1994, pp. 333-335. |
Molecular Cloning: A Laboratory Manual, Maniatis, T. et al., Cold Spring Harbor Laboratory, 1982. |
Design and Application of Antisense Oligonucleotides in Cell Culture, in Vivo, and as Therapeutic Agents, Brysch, W. et al., Cellular and Molecular Neurobiology, vol. 14, No. 5, 1994, pp. 557-568. |
Rational Design of Sequence-specific Oncogene Inhibitors Based on Antisense and Antigene Oligonucleotides, Helene, C., Eur. J. Cancer, vol. 27, No. 11, 1991, pp. 1466-1471. |
Optimization of Antisense Oligodeoxynucleotide Structure for Targeting ber-abl mRNA, Giles, R.V. et al., Blood, vol. 86, No. 2, 1995, pp. 744-754. |
Extending the chemistry that supports genetic information transfer in vivo: Phosphorothioate DNA, phosphorothioate RNA, 2'-O-methyl RNA, and methylphosphonate DNA, Thaler, D.S. et al., Proc. Natl. Acad. Sci. USA, vol. 93, 1996, pp. 1352-1356. |
Oligonucleotide N3'-P5' phosphoramidates as antisense agents, Gryaznov, S. et al., Nucleic Acids Research, vol. 24, No. 8, 1996, pp. 1508-1514. |
Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells, Lappalainen, K. et al., Biochimica et Biophysica Acta 1196, 1994, pp. 201-208. |
Block of AIDS-Kaposi's Sarcoma (KS) Cell Growth, Angiogenesis, and Lesion Formation in Nude Mice by Antisense Oligonucleotide Targeting Basic Fibroblast Growth Factor, Ensoli, B. et al., The Journal of Clinical Investigation, Inc., vol. 94, 1994, pp. 1736-1746. |
Growth Inhibition of Malignant CD5+B (B-1) Cells by Antisense IL-10 Oligonucleotide, Peng, B. et al., Leukemia Research, vol. 19, No. 3, 1995, pp. 159-167. |
Review: Optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter, Donovan, R.S. et al., Journal of Industrial Microbiology, 16, 1996, pp. 145-154. |
Prokaryotic gene expression in vitro: Transcription-translation coupled systems, Cenatiempo, Y., Biochimie, 68, 1986, pp. 505-515. |
Bacterial Regulation: Global Regulatory Networks, Gottesman, S., Ann, Rev. Genet., 18, 1984, pp. 415-441. |
Regulation In Vitro of a Cloned Mammalian Gene: Cadmium Induces the Transcription of a Mouse Metallothionein Gene in SV40 Vectors, Hamer, D.H. et al., Journal of Molecular and Applied Genetics, vol. 1, No. 4, 1982, pp. 273-288. |
Functional Relationships between Transcriptional Control Signals of the Thymidine Kinase Gene of Herpes Simplex Virus, McKnight, S.L., Cell, vol. 31, 1982, pp. 355-365. |
Isolation of the yeast regulatory gene GAL4 and analysis of its dosage effects on the galactose/melibiose regulon, Johnston, S.A. et al., Proc. Natl. Acad. Sci. USA, 79, 1982, pp. 6971-6975. |
In vivo sequence requirements of the SV40 early promoter region, Benoist, C. et al., Nature, vol. 290, 1981, pp. 304-310. |
Cloning, Structure, and Expression of the Mitochondrial Cytochrome P-450 Sterol 26-Hydroxylase, a Bile Acid Biosynthetic Enzyme, Andersson, S. et al., The Journal of Biological Chemistry, vol. 264, No. 14, 1989, pp. 8222-8229. |
Insulin and Insulin-like Growth Factor Signaling Are Defective in the MDA MB-468 Human Breast Cancer Cell Line, Sepp-Lorenzino, L. et al., Cell Growth & Differentiation, vol. 5, 1994, pp. 1077-1083. |
Biochemical Analysis of the Epithelin Receptor, Culouscou, J.M. et al., The Journal of Biological Chemistry, vol. 268, No. 14, 1993, pp. 10458-10462. |
Targeted Toxins as Anticancer Agents, Siegall, C.B., Cancer, vol. 74, No. 3, 1994, pp. 1006-1012. |
Zhang Haidi, “Overexpression of PC cell derived growth factor (PCDGF) contributes to the highly tumorigenic properties of producer cell line PC,” Diss. Abstr. Int., vol. 58, No. 11, 1998, p. 5814-B XP001025915, abstract. |
Vijay Bandhari and Andrew Bateman, “Structure and Chromosmal Location of the human granulin gene,” Biochemical and Biophysical Research Communications, vol. 188, No. 1, 1992, pp. 57-63, XP001018991, abstract, figure 2. |
Bhandari et al., “The Complementary Deoxyribonucleic Acid Sequence, Tissue Distribution, and Cellular Localization of the Rat Granulin Precursor,” Endocrinology, vol. 133, No. 6, 1993, pp. 2682-2689, XP001021601. |
Haidi Zhang and Ginette Serrero, “Inhibition of Tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor),” PNAS, vol. 95, Nov. 1998, pp. 14202-14207, XP002177206. |
European Search Report dated Oct. 23, 2001. |
Zhang, Haidi—“Overexpression of PC Cell Derived Growth Factor (PCDGF) Contributes To The Highly Tumorigenic Properties Of Producer Cell Line PC” a Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, Chemistry, Fall of 1997, 143 pages, Clarkson University. |
Vijay Bhandari, et al.—“Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domans,” Proc. Natl. Acad. Sci. USA, vol. 89, Mar. 1992, pp. 1715-1719. |
Runging Lue, et al.—“Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468,” PNAS, vol. 97, No. 8, Apr. 11, 2000, pp. 3993-3998. |
Zhiheng He, et al.—“Progranulin Gene Expression Regulates Epithelial Cell Growth and Promotes Tumor Growth in Vivo1,” Cancer Research 59, Jul. 1, 1999, pp. 3222-3229. |
International Search Report dated May 13, 2003. |